GlobalData

Asia-Pacific leads the market with a 43 per cent share, followed by North America and Europe

Major drivers of the growth include the projected launch of prophylactic options for the prevention of C. difficile,…

Brazil’s highly attractive pharmaceutical market to approach $30 billion by 2021, says GlobalData

The provision of a single vaccine that can protect the population against all prevalent serogroups is the most important…

The Huntington’s disease pipeline will see exciting new developments over the next decade as disease-modifying drugs transform the…

Mitsubishi Tanabe Pharma aims to launch the vaccine in the US for the 2018-19 flu season A new tobacco-based seasonal influenza…

The market will undergo significant changes, driven by mounting patient awareness of advancements in medical technology, and an…

Japan will see the most impressive relative growth, with sales expanding from $47 million in 2014 to $268 million in 2024

The increase represents a tepid CAGR of 1.52 per cent across Argentina and the seven major markets of the US, France, Italy,…

The report also states that Roche’s Rituxan has emerged as the most clinically and commercially attractive therapy that is used in…